GSK Belantamab Mafodotin shows to help blood cancer patients Medical Dialogues Bureau26 Aug 2019 3:45 AM GMTTwo doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford Medical Dialogues Bureau22 Aug 2019 4:00 AM GMTThe investment will add additional capacity and capabilities to a facility that makes some of Pfizer's most closely watched experimental...
GSK ends Ebola vaccine RnD; transfers license to US institute Medical Dialogues Bureau8 Aug 2019 4:00 AM GMTGSK had put its Ebola vaccine work on hold after it was unable to progress the product through the final stage, or Phase III, clinical trials toward...
Pfizer, GSK completes transaction to form new consumer healthcare JV Medical Dialogues Bureau3 Aug 2019 4:10 AM GMTThe Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1 Farhat Nasim2 Aug 2019 3:45 AM GMTThe company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said...
GSK drug Zejula helps ovarian cancer patients live longer in late-stage study Medical Dialogues Bureau16 July 2019 3:56 AM GMTGSK bought the drug when it acquired U.S. cancer specialist Tesaro for $5.1 billion in December and Zejula is already approved for certain ovarian...
Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL Farhat Nasim29 Jun 2019 6:26 AM GMTThe court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
GSK eyes sale of $1.2 billion consumer health drugs; says report Medical Dialogues Bureau22 Jun 2019 3:29 AM GMTGSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
GSK pharma head flags need for speed in high-pressure drug market Medical Dialogues Bureau18 Jun 2019 8:36 AM GMTLONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
GSK Nucala wins USFDA approval for two new self-administration options Farhat Nasim9 Jun 2019 4:30 AM GMTNucala is the first anti-IL5 biologic to be licensed in the US for at-home administration, and the first respiratory biologic to be approved for...
GSK Consumers Healthcare gets shareholders' nod for merger with HUL Medical Dialogues Bureau3 Jun 2019 4:00 AM GMTEarlier in January, GlaxoSmithKline (GSK) Consumer Healthcare had informed that it has received approval from the fair trade regulator CCI for its...
GSK, Pfizer gets CCI approval for consumer healthcare JV formation Garima25 May 2019 4:15 AM GMTAfter the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
